When HIV pays the price: Fitness costs behind lenacapavir resistance
HIV can take several mutational pathways to become resistant to lenacapavir, each with distinct resistance and fitness profiles (Pennetzdorfer <i>et al.</i>, this issue).
Authors
- Jonathan Z. Li (ORCID: https://orcid.org/0000-0001-9914-9662)
- Manish C. Choudhary (ORCID: https://orcid.org/0000-0002-3192-7840)
Institutions
- Brigham and Women's Hospital (US)
Publication Details
- Journal
- Science Translational Medicine
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1126/scitranslmed.aed6475
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00